Factors associated with drug-free remission at 5-year in early onset axial spondyloarthritis patients: Data from the DESIR cohort - D.E.S.I.R study Accéder directement au contenu
Article Dans Une Revue Joint Bone Spine Année : 2022

Factors associated with drug-free remission at 5-year in early onset axial spondyloarthritis patients: Data from the DESIR cohort

Résumé

ObjectivesTo assess the frequency of patients in drug-free remission at 5 years in a cohort of early axial SpA, and the factors associated with this remission.MethodsPatients: patients included in the DESIR (DEvenir des Spondyloarthropathies Indifférenciées Récentes) cohort undergoing the 5-year visit were selected for this analysis. Definition of 5-year drug-free remission: (1) all patients in ASAS partial remission and/or ASDAS < 1.3 at 5 year visit and (2) taking no disease modifying anti-rheumatic drugs at the 5-year visit and (3) with an ASAS-NSAID score ≤ 25 at the 5-year visit. Data analysis: the proportion of patients in drug-free remission was described. The association between demographic, clinical, biological and imaging characteristics and drug-free remission at 5 years was assessed by logistic regression.ResultsOf the 412 patients included in this analysis, 73 (18%) were in drug-free remission at the 5-year visit. The baseline clinical factors associated with the chances to be in drug-free remission at the 5-year visit were symptom duration (OR = 0.66 [95%CI%: 0.44–0.97]), lower HAQ-AS score (OR = 0.32 [0.12–0.78]), lower ASDAS score (OR = 0.55 [95%CI: 0.34–0.86]), ASAS-NSAID score (OR = 0.91 [95%CI: 0.82–0.99]). Furthermore, anti-TNF use (OR = 0.20 [95%CI: 0.08–0.42]) during the follow-up decreased the chances of being in 5-year drug-free remission.ConclusionThe probability of being in drug free remission at 5 year when beginning an axial SpA is low and is associated with lower baseline disease activity and functional scores, while starting an anti-TNF is associated with poor chances of later being in drug-free remission.
Fichier principal
Vignette du fichier
S1297319X22000173.pdf (282.34 Ko) Télécharger le fichier
Origine Fichiers produits par l'(les) auteur(s)

Dates et versions

hal-04003677 , version 1 (22-07-2024)

Licence

Identifiants

Citer

Adeline Ruyssen-Witrand, Vanessa Rousseau, Agnès Sommet, Philippe Goupille, Yannick Degboe, et al.. Factors associated with drug-free remission at 5-year in early onset axial spondyloarthritis patients: Data from the DESIR cohort. Joint Bone Spine, 2022, 89 (4), pp.105358. ⟨10.1016/j.jbspin.2022.105358⟩. ⟨hal-04003677⟩
9 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Mastodon Facebook X LinkedIn More